In the first antimicrobial screen using C. elegans, the standard agar-based infection assay was modified to form a liquid-based curing assay in a 96-well plate format for high-throughput screening of 6,000 individually synthesized molecules and 1,136 natural extracts, consisting mainly of plant and marine extracts, for their ability to rescue C. elegans following an Enterococcus faecalis persistent infection (Moy et al., 2006). This screen identified 16 synthetic compounds and nine natural extracts that promote survival of E. faecalis infected worms. From the antimicrobial test, 7 of the 16 compounds inhibited the replication of E. faecalis in vitro with minimum inhibitory concentrations (MICs) <31 μg/mL. The screen was refined to a fully automated process which scaled up the throughput of the screen from ∼7000 compounds to ∼37,000 unique molecules and natural product extracts. This allowed the identification of 80 antimicrobial agents that cured C. elegans from a E. faecalis infection, including 62 known antibiotics and 18 candidates with previously reported antibacterial effect or structural analogs of known antibiotics (Moy et al., 2009).

The initial study by Moy et al. (2009) prompted other initiatives to search for novel anti-infectives and these efforts have been fruitful. To identify novel therapeutic molecules toward S. aureus, our group developed a C. elegans–S. aureus screening platform to perform small-scale in vivo screens on extracts from plant and marine resources as well as synthetic molecules (Kong et al., 2014b). In contrast to E. faecalis that persists in the C. elegans intestinal tract, S. aureus infection of worms is transient (Sifri et al., 2003). By constant exposure of C. elegans to S. aureus in liquid medium, 70 candidates were subjected to the C. elegans–S. aureus screen and 28 positive hits (14 extracts and 14 compounds) were obtained. Of the 14 natural extracts, 7 of them demonstrated potential antimicrobial effect against S. aureus when tested in a standard MIC microdilution assay. Among the most effective antimicrobial candidates were the extract from Curcuma longa and its main active component, curcumin (Kong et al., 2014b). An automated high-throughput C. elegans antimicrobial screen was used to screen a compound library comprising of 640 FDA-approved drugs for novel antimicrobial molecules against methicillin-resistant S. aureus (MRSA) (Rajamuthiah et al., 2014). Of note, closantel, the drug used to eradicate helminths, was identified as a promising hit that significantly prolonged the survival of MRSA-infected C. elegans. In vitro MIC microdilution tests showed that closantel exerted antibacterial activity against a wide range of Gram-positive and Gram-negative bacteria at low effective concentrations. Interestingly, closantel was also effective against the vancomycin-resistant S. aureus (VRSA) with an MIC of 0.78 μg/mL. The compound library also contained some clinically relevant antibiotics and almost all of the antibiotics that were previously known to be effective against MRSA were also identified as positive hits in the screen, further validating the robustness of the screen in detecting highly potential anti-staphylococcal molecules for future therapeutics development (Rajamuthiah et al., 2014). Following this, the screen has been expanded to two other compound libraries consisting of 85,000 compounds (Kim W. et al., 2015) and ∼21,000 compounds (Rajamuthiah et al., 2015), respectively. One positive hit from the screen was 1-Hexadecyl-2-methyl-3-(phenylmethyl)-1H-imidazolium iodide (NH125), an antibiotic with well-characterized mode of action (Yamamoto et al., 2000). A further study revealed that NH125 was also able to kill persister cells and eradicate the formation of MRSA biofilm by penetrating the extracellular polymeric substance (EPS) matrix within an established biofilm (Kim W. et al., 2015). Additionally, a novel antibacterial compound, 3-(phenylsulfonyl)-2-pyrazinecarbonitrile (PSPC), rescued MRSA-infected worms. PSPC and its derivatives displayed high antibacterial efficacy toward Gram-positive bacteria, with higher MIC values observed against Gram-negative pathogens (Rajamuthiah et al., 2015). Yang et al. (2013) developed a simple, time-efficient and cost-effective integrated microfluidic-based C. elegans screening system to test the in vivo antimicrobial effect of various natural compounds. The three major active components of the natural product rhubarb (emodin, rhein, and aloe-emodin) enhanced the survival of worms challenged with S. aureus and inhibited S. aureus replication at ≤16 μg/mL but were toxic to the animals at concentrations >60 μg/mL (Yang et al., 2013).

A C. elegans–P. aeruginosa liquid-based slow-killing assay was used to perform an in vivo screen for potential anti-infective substances against multidrug-resistant P. aeruginosa. Screening a collection of 1,300 natural extracts mainly consisting of secondary metabolites from fungal endophytes of medicinal plants, led to the discovery of four extracts from four different fungal species with both in vivo and in vitro antimicrobial activity (Zhou et al., 2011). The in vivo activity and efficacy of naturally occurring antimicrobial peptides isolated from frog skin were also evaluated using a C. elegans infection model (Uccelletti et al., 2010). The peptides, temporin-1Tb and esculentin (1–18), promoted the survival of P. aeruginosa-infected worms. Exposure to the peptides for 24 h significantly reduced the intestinal bacterial load in worms pre-infected with P. aeruginosa. Taking advantage of the transparent nature of C. elegans, the in vivo effect of the peptides on membrane permeability was examined by firstly exposing the P. aeruginosa infected nematodes to Sytox Green followed by treatment with the peptides and subsequently, observation of fluorescence intensity within the intestine of C. elegans. The enhanced fluorescence intensity in treated infected nematodes indicated that the peptide killed P. aeruginosa in vivo by permeating the bacterial membrane. The findings from this study reinforced the fact that C. elegans can be used to investigate the in vivo mode of action of antimicrobial molecules within the context of a living animal.

The high-throughput C. elegans screening platform has been expanded to identify potential antimicrobial therapeutics against other pathogens that cause clinically significant morbidity and mortality such as Burkholderia pseudomallei (Lakshmanan et al., 2014) and A. baumannii (Jayamani et al., 2015). Lakshmanan et al. (2014) described a robust C. elegans based high-throughput screen to search for novel antibiotics to treat melioidosis, a highly lethal infection caused by the Gram-negative B. pseudomallei. As B. pseudomallei is a Tier-1 organism, a closely related species, Burkholderia thailandensis, was substituted as the surrogate pathogen in the screen. One of the hits identified from the pilot screen of ∼30,000 compounds was Clinafloxacin, a fourth generation fluoroquinolone antibiotic, which demonstrated diverse antibacterial activity against B. pseudomallei as well as other Gram-negative pathogens (Lakshmanan et al., 2014). The ability of A. baumannii to infect and kill C. elegans led to the development of a C. elegans–A. baumannii liquid infection assay to screen for potential anti-A. baumannii agents from a collection of synthetic insect-derived antimicrobial peptides. A promising hit was the antimicrobial peptide, cecropin A, isolated from the mosquito Aedes aegypti. Further analysis suggested that this peptide exerted its antimicrobial activity by disrupting the bacterial membrane, leading to cell lysis (Jayamani et al., 2015). The in vivo antimicrobial effect of small molecules identified from an in vitro growth inhibition assay was evaluated using a C. elegans–Burkholderia cenocepacia infection model. Identification of a compound with good in vitro activity without curing B. cenocepacia-infected nematodes from infection highlights the importance of using a live animal model for the discovery of antimicrobial compounds with promising in vivo efficacy (Selin et al., 2015). Other drugs and natural compounds that have been tested for their in vivo antimicrobial properties in the worm model are listed in Table 1.

In the first antimicrobial screen by Moy et al. (2006) the identification of hits that did not interfere with bacterial growth in vitro or hits with a lower effective concentration in vivo suggests that these compounds and extracts may either act by enhancing host immunity or altering pathogen virulence. The findings from this study also offer proof-of-concept that the C. elegans whole-animal antimicrobial screening platform is able to detect hits that may be missed in a conventional cell-culture based in vitro screen where the live host–pathogen relationship is absent (Moy et al., 2006). In addition to novel antimicrobial compounds, the automated high-throughput C. elegans screen by Moy et al. also identified potential anti-virulence compounds (Moy et al., 2009), including analogs of small molecules that were found to prevent P. aeruginosa biofilm development in another anti-biofilm screen (Junker and Clardy, 2007).

In an earlier study on the effect of compounds on bacterial virulence, the effect of salicylic acid, a type of phenolic compound produced naturally by plants, was tested on P. aeruginosa virulence in the worm model as well as the Arabidopsis thaliana plant model. Feeding the worms with salicylic acid-treated P. aeruginosa prolonged worm survival compared to the worms exposed to untreated bacteria. Microarray and biochemical analyses proposed that this compound reduced the virulence of P. aeruginosa by inhibiting the production of biofilm, pyocyanin, protease, and elastase (Prithiviraj et al., 2005). Following this, the anti-virulence potential of extracts from three medicinal plants (Conocarpus erectus, Callistemon viminalis, and Bucida buceras) was assessed against P. aeruginosa using the C. elegans paralytic killing, fast-killing and slow-killing models. These extracts were known to affect bacterial quorum sensing (Adonizio et al., 2008a). Addition of the individual extracts into the solid agar medium significantly delayed the killing of nematodes by P. aeruginosa to a rate similar to worms fed with the P. aeruginosa lasR quorum sensing mutant, suggesting that these extracts most likely targeted the bacterial quorum sensing pathway (Adonizio et al., 2008b). A similar approach was also used to elucidate the anti-virulence properties of curcumin, the main bioactive component present in turmeric. Curcumin rescued C. elegans from a P. aeruginosa (PAO1) infection via the inhibition of various virulence factors, including pyocyanin, biofilm, acyl homoserine lactone, and bacterial quorum sensing (Rudrappa and Bais, 2008). In addition to its anti-virulence effect on P. aeruginosa, curcumin is also able to rescue worms from a B. pseudomallei-inflicted infection. We showed that curcumin interfered with B. pseudomallei iron acquisition and also inhibited the production of B. pseudomallei lipase, protease as well as biofilm without affecting bacterial viability. This suggests the potential of curcumin as an alternative therapy for the highly lethal melioidosis caused by B. pseudomallei (Eng and Nathan, 2015). In a recent study, curcumin was reported to interfere with bacterial virulence in a mouse model of lung infection, providing an independent validation of the anti-virulence effect identified in a C. elegans model (Wang et al., 2016).

Quorum sensing is a complicated cell-to-cell communication system that regulates the expression of various key virulence factors in Gram-positive and Gram-negative bacteria, making it a target of interest for anti-virulence therapy. The P. aeruginosa quorum sensing system utilizes acyl homoserine lactones as autoinducer molecules to regulate and direct the expression of virulence and biofilm-associated genes (Williams et al., 2007). Other natural inhibitors that have been tested for their anti-virulence effect in vivo using the C. elegans–P. aeruginosa infection model are the methanolic extract of Terminalia chebula fruit (Sarabhai et al., 2013), extract and active compound of Dalbergia trichocarpa bark (Rasamiravaka et al., 2015), tea polyphenols extracted from the leaf of Camellia sinensis L. (Yin et al., 2015), the methanolic extract of Trigonella foenum-graecum L. seed (Husain et al., 2015b), Syzygium aromaticum (clove) oil (Husain et al., 2013), and Mentha piperita (peppermint) oil (Husain et al., 2015a). In addition to targeting quorum sensing circuits, chemical compounds such as phenylacetic acid (Musthafa et al., 2012b), 2,5-piperazinedione (Musthafa et al., 2012a) and meta-bromo-thiolactone (O’Loughlin et al., 2013) as well as the hormonal therapy drug raloxifene (Ho Sui et al., 2012) inhibited P. aeruginosa pyocyanin production and reduced bacterial virulence in the nematode model. Other virulence determinants, including biofilm, proteases and elastase, as well as bacterial motility, were also suppressed by most of these molecules. Compounds targeting the iron-regulation pathway that alleviated P. aeruginosa-mediated killing of C. elegans were identified from a high-throughput liquid-based chemical screen (Kirienko et al., 2013). Recently, an anti-proliferative drug, 5-fluorouracil, was shown to enhance the survival of P. aeruginosa-infected C. elegans via disruption of pyoverdine biosynthesis (Kirienko et al., 2016). Interestingly, in an independent study, 5-fluorocytosine (a 5-fluorouracil precursor) demonstrated the ability to inhibit pyoverdine production in vivo in a mouse model of P. aeruginosa lung infection (Imperi et al., 2013). This compound also diminished P. aeruginosa virulence by targeting biofilm formation and quorum-sensing phenotypes in vitro (Ueda et al., 2009). Moreover, garlic extract also displayed anti-quorum sensing effect against P. aeruginosa in both nematode (Rasmussen et al., 2005) and mice models (Bjarnsholt et al., 2005; Harjai et al., 2010). Together, these findings demonstrate the successfully translation of the anti-virulence effect identified in a C. elegans model in a higher organism and provides a positive correlation between the compound activity identified in a C. elegans model with a more complex mammalian infection model. Through in silico drug design and model simulations, two chemical entities were identified as inhibitors of P. aeruginosa heme oxygenase. One of these compounds prolonged the lifespan of infected nematodes and decreased bacterial colony forming units in the C. elegans intestine, albeit showing poor antimicrobial activity in vitro (Hom et al., 2013). Recently, Zhu et al. (2015) used the C. elegans model to characterize an inhibitor of LasB, a vital virulence factor of P. aeruginosa. Cross-sectional transmission electron microscopy images of the C. elegans intestine displayed less host tissue damage upon treatment with the LasB inhibitor, suggesting that P. aeruginosa was rendered less virulent by the compound (Zhu et al., 2015).

Staphylococcus aureus is continuously acquiring resistance to clinically used antibiotics, underlining the need for new anti-virulence therapeutics against this pathogen. The ability of S. aureus to produce biofilm has complicated treatment by blocking the antibiotics penetration of the cells encased within the exopolysaccharide material. Hence, S. aureus biofilm and the quorum sensing system are attractive targets for anti-virulence therapeutics. Several natural compounds with in vitro anti-biofilm property have been demonstrated to attenuate S. aureus virulence in vivo in a C. elegans model. This includes essential oils from various plants (Lee J.H. et al., 2014; Lee et al., 2014a), red wine (Cho et al., 2015), stilbenes and the natural phenol, resveratrol (Lee J.H. et al., 2014; Lee et al., 2014b). Moreover, these natural products also reduced blood hemolysis caused by S. aureus hemolysins. The colonization of S. aureus in the worm intestine can be determined by staining the bacteria with acridine orange dye. Using this approach, the reduction of in vivo bacterial loads by an extract from a coral actinomycete was reported (Bakkiyaraj and Pandian, 2010). Hamamelitannin, the active component isolated from American witch hazel, has recently been shown to act as an inhibitor of the S. aureus quorum sensing mechanism. This compound and its analogs effectively improved the susceptibility of S. aureus biofilms to multiple antibiotics treatment both in vitro and in vivo (C. elegans and mouse infection models) (Brackman et al., 2016).

The uracil-auxotroph E. coli strain OP50 is routinely used as the laboratory-based food source for C. elegans, however, some pathogenic E. coli strains are lethal on worms. E. coli O157:H7 is a toxin-producing enterohemorrhagic strain with noteworthy medical implications. Broccoli extract and its associated flavonoid compounds were able to impede the virulence of this E. coli strain in the nematode model by inhibiting a number of vital virulence genes as well as the swarming motility of E. coli O157:H7 (Lee et al., 2011). Screening a collection of plant secondary metabolites for anti-biofilm activity against E. coli O157:H7 also identified several coumarin derivatives that were subsequently shown to suppress pathogen virulence in vivo in the C. elegans infection system (Lee J.H. et al., 2014). Lavigne et al. (2008) utilized the C. elegans model to compare virulence of E. coli strains isolated from urine samples of individuals who consumed either cranberry or placebo capsules. E. coli strains from patients who took regular cranberry capsules displayed reduced adherence in vitro and delayed killing of C. elegans (Lavigne et al., 2008). Apart from this, the C. elegans model has also been used to screen for anti-virulence compounds from a collection of ∼250 marine sponge associated bacterial extracts for their ability to rescue the nematodes from a Vibrio alginolyticus infection (Durai et al., 2013). The active ingredients isolated from plants and seawater bacteria inhibited Vibrio cholerae biofilm production and reduced V. cholerae virulence in the killing of nematodes (Kim H.I. et al., 2015; Rajalaxmi et al., 2016). Natural compounds that affected the virulence of Gram-positive Clostridium difficile (Yun et al., 2015) and Listeria monocytogenes (Silva et al., 2015; Sivaranjani et al., 2016) have also been recently described.

Despite lacking an adaptive immune system, C. elegans is still capable of activating protective mechanisms when confronted with pathogenic microorganisms in its natural habitat. The worms mount a complex and non-specific ancestral immune response, involving the activation of multiple signal transduction pathways and the secretion of immune effector molecules (Ermolaeva and Schumacher, 2014). This makes the identification of compounds targeting the host innate immune system possible using the C. elegans-based infection system. Following the initial high-throughput antimicrobial screen by Moy et al. (2009), the compound RPW-24 was shown to extend the lifespan of P. aeruginosa-infected worms without compromising bacterial integrity (Pukkila-Worley et al., 2012). By employing various approaches including microarray analysis using the readily available Affymetrix full-genome C. elegans GeneChip, as well as pathway elucidation studies using transgenic GFP reporter and mutant worms, the effect of the compound on host immunity was further characterized. RPW-24 was found to protect the worms from bacterial infection by inducing the p38 MAP kinase pathway-mediated response and the transcription factor ATF-7, suggesting the utility of the C. elegans model to discover novel strategies effective in treating bacterial infections (Pukkila-Worley et al., 2012). The extract from Swietenia macrophylla seeds promoted the survival of P. aeruginosa-challenged nematodes by boosting the expression of a C. elegans lysozyme encoding gene (lys-7) as observed by increasing fluorescence intensity in lys-7::GFP transgenic worms (Dharmalingam et al., 2012). Similarly, the nematodes subjected to P. aeruginosa infection were rescued by supplementation with dietary selenium. Selenite treatment did not interfere with bacterial quorum sensing and virulence, but elevated the transcript levels of host putative antimicrobial genes such as lys-1, spp-1, and abf-1. It was also demonstrated that the pathogen-resistant phenotype conferred by selenite requires the presence of a functional SKN-1 in C. elegans (Li et al., 2014).

From the C. elegans–S. aureus anti-infective screen discussed in Section “Compounds with In vivo Antimicrobial Activity,” our group identified an extract from a local plant, Orthosiphon stamineus, as a potential immunomodulatory drug that enhanced host tolerance toward a deadly S. aureus infection. This extract was not antimicrobial per se and is non-toxic to the C. elegans model. Expression of the host lys-7 antimicrobial gene in untreated worms was suppressed after 24 and 48 h exposure to S. aureus. This suppression is mediated by the pathogen’s ability to alter the host defense mechanism, particularly the host antimicrobial response. As noted through observations of a fluorescing transgenic strain infected by S. aureus, the down-regulation of lys-7 was restored in the presence of O. stamineus extract. Analysis using a loss-of-function C. elegans mutant established that the protective role of this extract is mediated via the conserved p38 MAPK and daf-2/daf-16 insulin-like signaling pathways. qRT-PCR analysis of the host PMK-1 and DAF-16-regulated antimicrobial genes confirmed a significant positive modulation of these genes in S. aureus-infected worms exposed to O. stamineus extract. Further studies also revealed eupatorin as the major bioactive ingredient that contributed to the immunomodulation effect of O. stamineus (Kong et al., 2014a). In a separate study, O. stamineus extract also modulated the cellular immune response in vitro (Alshawsh et al., 2012). Similarly, the natural polyphenols isolated from Magnolia plant species, honokiol and magnolol, promoted a cellular immune response and slowed down C. elegans killing by S. aureus (Choi et al., 2015).

Host-directed immunomodulators offer a number of potential advantages over antimicrobial drugs. Targeting the host immunity in combating pathogen infection is an appealing approach as the stimulation or modulation of host immune function may promote resistance against a diverse array of pathogens, forming the basis of broad spectrum therapeutics to treat infections (Nijnik, 2013). Additionally, it may lower the risk of selection toward treatment resistance. The water-soluble cranberry extract was reported to up-regulate the expression of C. elegans innate immune genes and confer protection against various major pathogens, namely V. cholerae, E. coli O157:H7, P. aeruginosa, Salmonella typhimurium, S. aureus, and E. faecalis (Dinh et al., 2014). Specifically, the protective effect of this extract against V. cholerae is dependent on the p38 MAPK signaling pathway. The wide spectrum activity of other immunomodulatory compounds has also been seen for the alkaloid compounds harmane and colistin. Harmane promoted survival in nematodes infected by both Gram positive and Gram negative pathogens, including E. coli strain EDL933, S. typhimurium, P. aeruginosa, and E. faecalis (Jakobsen et al., 2013). Cai et al. (2014) developed a C. elegans – based chemical screen for the discovery of immune-inductive drugs using the F35E12.5::gfp transgenic strain and they identified the antibiotic colistin as a potential hit. The nematodes pre-treated with colistin were also resistant against Yersinia pestis and P. aeruginosa infections (Cai et al., 2014).

Concomitantly, some anti-infectives may exhibit both anti-virulence and immunomodulatory effects. The water extract of red seaweed Chondrus crispus exerted dual anti-infective effects by simultaneously disabling the virulence of P. aeruginosa and elevating host immunity to combat pathogen infection. C. crispus down-regulated mRNA levels of quorum sensing and virulence-related genes and retarded the secretion of P. aeruginosa virulence factors such as protease, elastase, pyocyanin, siderophore, hydrogen cyanide, and biofilm (Liu et al., 2013). Furthermore, the protective effect of C. crispus extract was diminished in selected C. elegans mutants (pmk-1, daf-2, daf-16, or skn-1), implying that the effect from the host perspective is mediated via the highly conserved immune pathways. Likewise, concurrent virulence inhibitory and immunostimulatory effects have also been observed in other seaweed-related natural products, including Tasco^®, a commercially available animal feed supplement made from the brown seaweed Ascophyllum nodosum (Kandasamy et al., 2012) and another red seaweed species Sarcodiotheca gaudichaudii (Kulshreshtha et al., 2016). Both, S. gaudichaudii and C. crispus extracts disarmed the pathogenicity of Salmonella enteritidis by reducing biofilm formation, swimming and swarming motility and down-regulating expression of virulence and quorum sensing genes in S. enteritidis. These extracts also reduced the intestinal bacterial load in C. elegans by promoting the expression of host immune response genes encoding lectin-family, saponin-like and antibacterial proteins (Kulshreshtha et al., 2016). Whilst no direct evidence of seaweed extract exerting an immunomodulatory effect on animal infection-directed immune responses, is available, Luo et al. (2015) demonstrated that seaweed polysaccharide was immunomodulatory in a cell-culture based assay as well as in a mouse tumor model. The seaweed polysaccharide enhanced the tumor immune response by increasing the number of tumor-infiltrating immune-related cells in the murine lymphoma model. The various experimental procedures used to scrutinize the mode of action of a compound targeting bacterial virulence and/or host immunity are outlined in Figure 2.

Although, therapeutics that involve the immune system can be broad spectrum against a wide variety of infecting agents, overstimulation or dysregulation can lead to potential harmful side effects such as uncontrolled inflammatory response that may cause tissue damage or even worse, immunosuppression that may result in the shutdown of the entire immune system. For example, the immunomodulatory drug RPW-24 generally induced a C. elegans detoxification pathway and triggered C. elegans aversion behavior under an uninfected condition. Concurrently, the basal lifespan of the uninfected population was also shortened and the development of C. elegans larva was halted upon exposure to this compound (Pukkila-Worley et al., 2012). Therefore, the mechanism of immunostimulatory molecules must be carefully investigated to maximize the beneficial effect and at the same time minimizing the possible toxic effects. Furthermore, the precise mode of drug administration (e.g., prophylactic or during infection) should also be determined to ensure effective treatment.

Examination of the worm’s genome led to the discovery of saposin-like peptides/proteins (SPPs) characterized by an α-helix bundle stabilized by three unique disulphide bonds (Bruhn, 2005). Alternatively, they are named as caenopores owing to their structural and functional resemblance with amoebapores as they consist of a secretory signal peptide followed by saposin-like domain (Roeder et al., 2010). Given that most spp gene expression is regulated by the intestine specific transcription factor ELT-2, it is likely that caenopores are exclusively expressed in the intestine (Hoeckendorf and Leippe, 2012; Hoeckendorf et al., 2012). The direct role for caenopores in the innate immune response of C. elegans was first reported in Banyai and Patthy (1998) when the antibacterial effect of recombinant SPP-1 was observed on E. coli. Like amoebapores, SPP-5 was shown to display pore-forming activity and kill bacteria by permeabilising the cytoplasmic membrane (Roeder et al., 2010). A detailed examination of three-dimensional structure revealed that SPP-5 has five amphiphatic helices, connected by three disulfide bonds arranged like a folded leaf, which is the signature of the SAPLIP family (Mysliwy et al., 2010). It was worth noting that this was the first and only representative structure solved for C. elegans APPs. The molecular mechanism underlying pore formation however remains unclear.

A total of six ASABF (Ascaris suum antibacterial factor) homologs or best known as antibacterial factor (ABF-1 to ABF-6) peptides/proteins have been identified in C. elegans. ASABF is a cysteine-rich microbicidal factor that was first discovered in the body fluid of the nematode A. suum (Kato and Komatsu, 1996). It is possible that ABFs are also part of the C. elegans defense mechanism as exposure to pathogens led to the up-regulation of abf genes (Alegado et al., 2003; Alper et al., 2007; Means et al., 2009). By means of RNAi-mediated gene silencing, the functional significance of ABFs was further characterized. Silencing one of these genes, abf-2, led to increased bacterial load in the intestinal lumen (Alegado et al., 2003). It is well-established that expression of abf genes is localized primarily at the site of contact with bacteria, i.e., in the digestive tract (Alper et al., 2007). To date, only recombinant ABF-2 is known to display broad-spectrum antimicrobial activity, with the greatest effect observed toward Gram-positive bacteria (Kato et al., 2002). The precise role(s) of other members of this family are still unclear and required further analysis.

Caenorhabditis elegans harbors protist-type (lys-1 to lys-10) and invertebrate type (ilys-1 to ilys-6) lysozyme encoding genes (Schulenburg and Boehnisch, 2008; Tarr, 2012). Representative members of the latter are up-regulated upon exposure to various pathogen insults (Irazoqui et al., 2010), suggesting possible roles involved in host defense. Studies using recombinant ILYS-3 have reported that the protein displays lytic activity against the Gram-positive Micrococcus luteus and M. nematophilum. It is known that invertebrate lysozymes are able to cleave the isopeptide bonds established between D-glutamate and L-Lysine present in peptidoglycans (Tarr, 2012; Van Herreweghe and Michiels, 2012). The importance of invertebrate lysozymes for host defense was recently confirmed when Gravato-Nobre et al. (2016) reported that disruption of ilys-3 renders the mutant worms more susceptible to M. nematophilum. The investigators also elegantly showed that ILYS-3 is primarily produced in the C. elegans digestive tract (Gravato-Nobre et al., 2016). For additional information of the protist-type lysozymes, readers are referred to previous reviews (Schulenburg and Boehnisch, 2008; Ewbank and Zugasti, 2011).

In C. elegans, most of the neuropeptide-like peptides/proteins (nlp) genes were named as such because of their limited sequence similarity with YGGXamide neuropeptide genes, sharing the YGGWG and YGGYG motifs (Nathoo et al., 2001). These genes form “the nlp-29 cluster” which comprises nlp-27 to nlp-31 and the adjacent gene nlp-34 on chromosome V (Couillault et al., 2004; Pujol et al., 2008). Upon exposure to the nematode-trapping fungus Monacrosporium haptotylum, several nlp genes were induced in infected worms (Fekete et al., 2008). Overexpression of these genes enhanced worm resistance to D. coniospora infection, further validating their contribution to in vivo host defense (Pujol et al., 2008). Couillault et al. (2004) demonstrated that the 53-amino-acid synthetic NLP-31 has potent antimicrobial activity against fungi and several bacteria. Utilizing transgenic worms expressing GFP under the control of the nlp-31 promoter, these investigators also demonstrated that this gene is exclusively expressed in the hypodermis. Recent work from our group has proposed an immunomodulatory role for NLP-31 as the peptide regulated the expression of inflammatory cytokines in B. pseudomallei-infected macrophage cells. Several lines of evidence suggest that it employs a mechanism that does not involve membrane permeabilisation, but instead interact with cytoplasmic macromolecules to interfere with the viability of B. pseudomallei (Lim et al., 2016).